The 7th International Conference on Polyphenols and Health

Nutrition Bulletin

Volumn 41, Issue 1, 2016, Pages 92-95

  Hollman, P C H ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84958267670     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/nbu.12194     Document Type: Article

References (10)

1. Arumugam M, Raes J, Pelletier E et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174-80.
2. Auclair S, Milenkovic D, Besson C et al. (2009) Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 204: e21-7.
3. Estruch R, Ros E, Salas-Salvado J et al. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 368: 1279-90.
4. Gonzalez-Sarrias A, Tome-Carneiro J, Bellesia A et al. (2015) The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food & Function 6: 1460-9.
5. Kandaswami C, Lee LT, Lee PP et al. (2005) The antitumor activities of flavonoids. In Vivo 19: 895-909.
6. Le Chatelier E, Nielsen T, Qin J et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-6.
7. Liu K, Zhou R, Wang B et al. (2013) Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. American Journal of Clinical Nutrition 98: 340-8.
8. Qin J, Li R, Raes J et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
9. Qin J, Li Y, Cai Z et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
10. Rodriguez-Mateos A, Vauzour D, Krueger CG et al. (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Archives of Toxicology 88: 1803-53.